HER2-positive gastric cancer

N Boku - Gastric cancer, 2014 - Springer
Human epidermal growth factor receptor 2 (HER2) is involved in the pathogenesis and poor
outcomes of several types of cancer, including advanced gastric and gastroesophageal …

Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, D Cooke… - Journal of the National …, 2023 - jnccn.org
Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease

MA Shah, DP Kelsen - Journal of the National Comprehensive Cancer …, 2010 - jnccn.org
Gastric cancer is a cause of significant morbidity and cancer-related mortality worldwide.
Despite recent advances in targeted therapy and understanding of the biology and …

Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, J Chao… - Journal of the National …, 2019 - jnccn.org
Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide.
Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and …

Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem… - Journal of the National …, 2016 - jnccn.org
Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of
death from cancer in the world. Several advances have been made in the staging …

Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma

M Kakiuchi, T Nishizawa, H Ueda, K Gotoh, A Tanaka… - Nature …, 2014 - nature.com
Diffuse-type gastric carcinoma (DGC) is characterized by a highly malignant phenotype with
prominent infiltration and stromal induction. We performed whole-exome sequencing on 30 …

Gastric cancer, version 2.2013

JA Ajani, DJ Bentrem, S Besh, TA D'Amico… - Journal of the national …, 2013 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer provide evidence-
and consensus-based recommendations for a multidisciplinary approach for the …

Esophageal and esophagogastric junction cancers, version 1.2015

JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem… - Journal of the National …, 2015 - jnccn.org
Esophageal cancer is the sixth most common cause of cancer deaths worldwide.
Adenocarcinoma is more common in North America and Western European countries …

[HTML][HTML] S3-Leitlinie Magenkarzinom–Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs–Langversion 2.0–August …

M Moehler, SE Al-Batran, T Andus… - Zeitschrift für …, 2019 - thieme-connect.com
In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

German S3-guideline" Diagnosis and treatment of esophagogastric cancer"

M Moehler, SE Al-Batran, T Andus… - Zeitschrift fur …, 2011 - pubmed.ncbi.nlm.nih.gov
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"] [German S3-guideline
"Diagnosis and treatment of esophagogastric cancer"] Z Gastroenterol. 2011 Apr;49(4):461-531 …